Characteristics of Apoptosis Induction by the Alkaloid Emetine in Human Tumour Cell Lines

Abstract

Cytotoxic and apoptosis-inducing effects of the alkaloid emetine from Psychotria ipecacuanha (Rubiaceae) were studied in human cell lines. In Jurkat T-cells emetine leads to phosphatidylserine exposure, mitochondrial depolarisation, and DNA fragmentation. Furthermore, activation of several caspases (caspase-3, -9/6, and -8) was demonstrated in a fluorescent caspase assay. Bcl-2 over-expressing cells are less sensitive to emetine while caspase-8-deficient Jurkat T-cells react similarly to wild-type cells. This indicates that apoptosis induction is mediated via the mitochondrial pathway. By using hepatoma cell lines with differing p53 expression, it was concluded that p53 does not seem to play a role in apoptosis induction by emetine. Alterations of protein profiles during emetine-induced apoptosis were analysed by 2D-PAGE and MALDI-TOF-MS. A new protein spot was apparent after treatment with emetine: It could be identified as the N-terminal fragment lamin B1, which is released after cleavage by caspase-6.

Key words

Emetine - apoptosis - caspases - bcl-2 - p53 status - proteomics

References

• 1 Fulda S, Debatin K M. Exploiting death receptor signaling pathways for tumor therapy.  Biochim Biophys Acta. 2004;  1705 27-41.
• 2 Herr I, Debatin K M. Cellular stress response and apoptosis in cancer therapy.  Blood. 2001;  98 2603-14.
• 3 Wink M. Molecular modes of action of cytotoxic alkaloids - From DNA intercalation, spindle poisoning, topoisomerase inhibition to apoptosis and multiple drug resistance. In: Cordell G, editor The Alkaloids. New York, London; Academic Press 2007: p xx-xx.
• 4 Vedder E B. An experimental study of the action of ipecacuanha on amoeba.  J Trop Med Hyg. 1912;  15 313-4.
• 5 Lewisohn R. Action of emetin on malignant tumors.  JAMA. 1918;  70 9-10.
• 6 Panettiere F, Coltman CA J r. Experience with emetine hydrochloride (NSC 33 669) as an antitumor agent.  Cancer. 1971;  27 835-41.
• 7 Kane R C, Cohen M H, Broder L E, Bull M I, Creaven P J, Fossieck BE J r. Phase I - II evaluation of emetine (NSC-33 669) in the treatment of epidermoid bronchogenic carcinoma.  Cancer Chemother Rep. 1975;  59 1171-2.
• 8 Siddiqui S, Firat D, Olshin S. Phase II study of emetine (NSC-33 669) in the treatment of solid tumors.  Cancer Chemother Rep. 1973;  57 423-8.
• 9 Moertel C G, Schutt A J, Hahn R G, Reitemeier R J. Treatment of advanced gastrointestinal cancer with ememtine (NSC-33 669).  Cancer Chemother Rep. 1974;  58 229-32.
• 10 Street E W. Cyclophosphamide plus emetine in lung cancer.  Lancet. 1972;  2 381-2.
• 11 Mastrangelo M J, Grage T B, Bellet R E, Weiss A J. A phase I study of emetine hydrochloride (NSC 33 669) in solid tumors.  Cancer. 1973;  31 1170-5.
• 12 Bell D R. Treatment of amoebiasis.  Trop Doct. 1973;  3 140-3.
• 13 Knight R. The chemotherapy of amoebiasis.  J Antimicrob Chemother. 1980;  6 577-93.
• 14 Von Hoff D D, Rozencweig M, Soper W T. Whatever happened to NSC? An analysis of clinical results of discontinued anticancer agents.  Cancer Treat Rep. 1977;  61 759-68.
• 15 Grollman A P, Huang M T. Inhibitors of protein synthesis in eukaryotes: tools in cell research.  Fed Proc. 1973;  32 1673-8.
• 16 Grollman A P. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics.  Proc Natl Acad Sci USA. 1966;  56 1867-74.
• 17 Galasinski W, Chlabicz J, Paszkiewicz-Gadek A, Marcinkiewicz C, Gindzienski A. The substances of plant origin that inhibit protein biosynthesis.  Acta Pol Pharm. 1996;  53 311-8.
• 18 Wink M. Evolution of secondary metabolites from an ecological and molecular phylogenetic perspective.  Phytochemistry. 2003;  64 3-19.
• 19 Kochi S K, Collier R J. DNA fragmentation and cytolysis in U937 cells treated with diphtheria toxin or other inhibitors of protein synthesis.  Exp Cell Res. 1993;  208 296-302.
• 20 Bicknell G R, Snowden R T, Cohen G M. Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line U937.  J Cell Sci. 1994;  107 2483-9.
• 21 Watanabe N, Iwamoto T, Dickinson D A, Iles K E, Forman H J. Activation of the mitochondrial caspase cascade in the absence of protein synthesis does not require c-Jun N-terminal kinase.  Arch Biochem Biophys. 2002;  405 231-40.
• 22 Beidler D R, Ahuja D, Wicha M S, Toogood P L. Inhibition of protein synthesis by didemnin B is not sufficient to induce apoptosis in human mammary carcinoma (MCF7) cells.  Biochem Pharmacol. 1999;  58 1067-74.
• 23 Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays.  J Immunol Methods. 1983;  65 55-63.
• 24 Willingham M C. Cytochemical methods for the detection of apoptosis.  J Histochem Cytochem. 1999;  47 1101-9.
• 25 Cossarizza A, Ceccarelli D, Masini A. Functional heterogeneity of an isolated mitochondrial population revealed by cytofluorometric analysis at the single organelle level.  Exp Cell Res. 1996;  222 84-94.
• 26 Nicoletti I, Migliorati G, Pagliacci M C, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry.  J Immunol Methods. 1991;  139 271-9.
• 27 Görg A, Postel W, Günther S. The current state of two-dimensional electrophoresis with immobilized pH gradients.  Electrophoresis. 1988;  9 531-46.
• 28 Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.  Nature. 1970;  227 680-5.
• 29 Havlis J, Thomas H, Sebela M, Shevchenko A. Fast-response proteomics by accelerated in-gel digestion of proteins.  Anal Chem. 2003;  75 1300-6.
• 30 Möller M, Weiss J, Wink M. Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1/ABCB1) in human Caco-2 cells and leukemia cell lines.  Planta Med. 2006;  72 1121-6.
• 31 Evan G, Littlewood T. A matter of life and cell death.  Science. 1998;  281 1317-22.
• 32 Broers J L, Bronnenberg N M, Kuijpers H J, Schutte B, Hutchison C J, Ramaekers F C. Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis.  Eur J Cell Biol. 2002;  81 677-91.
• 33 Thiede B, Dimmler C, Siejak F, Rudel T. Predominant identification of RNA-binding proteins in Fas-induced apoptosis by proteome analysis.  J Biol Chem. 2001;  276 26 044-50.
• 34 Brockstedt E, Rickers A, Kostka S, Laubersheimer A, Doerken B, Wittmann-Liebold B. et al . Identification of apoptosis-associated proteins in a human Burkitt lymphoma cell line. Cleavage of heterogeneous nuclear ribonucleoprotein A1 by caspase 3.  J Biol Chem. 1998;  273 28 057-64.
• 35 Gerner C, Frohwein U, Gotzmann J, Bayer E, Gelbmann D, Bursch W. et al . The Fas-induced apoptosis analyzed by high throughput proteome analysis.  J Biol Chem. 2000;  275 39 018-26.
• 36 Wan J, Wang J, Cheng H, Yu Y, Xing G, Qiu Z. et al . Proteomic analysis of apoptosis initiation induced by all-trans retinoic acid in human acute promyelocytic leukemia cells.  Electrophoresis. 2001;  22 3026-37.
• 37 Verrills N M, Walsh B J, Cobon G S, Hains P G, Kavallaris M. Proteome analysis of Vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations.  J Biol Chem. 2003;  278 45 082-93.
• 38 Möller A, Soldan M, Völker U, Maser E. Two-dimensional gel electrophoresis: a powerful method to elucidate cellular responses to toxic compounds.  Toxicology. 2001;  160 129-38.